Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Ask Vendit Off-Topic Questions -- Ignore unavailable to you. Want to Upgrade?

To: Walkingshadow who wrote (6099)	3/7/2005 12:05:05 PM
From: Jill	Read Replies (1) \| Respond to of 8752

Perhaps its the nature of the death--sounds so gruesome, a fatal viral brain disease. Not that death isn't death, but a heart attack doesn't "sound" so bad. I'm not watching the market today but I'm tempted to buy some elan and sock it away, if it's still around 6 bucks and bases there...my hunch is that it was the combo of immune modulators that was the problem...it would be nice if they could find earlier signs. Many drugs out there cause fatal liver damage for instance in rare cases--fluconazole, lamisil, and I think serzone? They all remain on the market and flourishing. Let me know what you think of the RNAI silencing article...ALNY as you point out might also be a long term if somewhat risky hold. And I kind of like MYGN also which I asked Reid to put on the watch list. But I can't do much today and will look at this stuff tonight--hope we can "talk" on the board tonite...